Loading…
Raytec Biotechnology signed an agreement to build a regenerative medicine R&D and production base in Chengdu Medical City, Wenjiang District, including 6 production lines for medical restorative devices. The project is part of a 16-project signing event with total investment of approximately 12.4 billion yuan.
| Site | Largest | Latest |
|---|---|---|
| Chengdu Medical City, China | 2020-09-16 |